Introduction. Intraoperative periprosthetic femoral fractures (IOPFF) lead to reduced implant survival. A deeper understanding of predictors enables surgeons to modify techniques and patient selection to reduce the risk of IOPFF. The aim of this study was to estimate predictors of IOPFF and each anatomical subtype (calcar crack, trochanteric fracture, femoral shaft fracture) during primary THA. Methods. This retrospective cohort study included 793823 primary THAs between 2004 and 2016. Relative risks for patient, surgical and implant factors are estimated for any IOPFF fracture and for all anatomical subtypes of IOPFF. Results. Patient factors significantly increasing the risk of fracture were: female gender, American Association of Anaesthesiologists (ASA) grade 3 to 5, pre-operative diagnosis including: avascular necrosis of the hip (AVN), previous trauma, inflammatory disease, paediatric disease and previous infection. Overall risk of IOPFF associated with age was greatest in patients below 50 years and above 80 years. Risk of any fracture reduced with computer guided surgery (CGS) and in non-NHS hospitals. Non-posterior approach's increased the risk of shaft and trochanteric fracture only. Cementless implants only significantly increased the risk of calcar cracks and shaft fractures and not trochanteric fractures. Conclusions. Fracture risk increases in patients less than 50 and older than 80, females, ASA grade 3 to 5 and indications other than primary osteoarthritis. Large cumulative reduction in IOPFF risk may occur with use of cemented implants, posterior approach and CGS. IOPFF may be further reduced by future developments in cementless stem implantation and non-posterior approaches which reduce the intraoperative strain placed on the femora

Hip fusion is an uncommon procedure. Hip fusion takedown, therefore, is equally an uncommon procedure. What is of considerable interest is that the results, which I achieved in 20 cases in a paper published in 1987 are considerably superior to the results, which I am achieving today. This suggests that no simple case is now fused. It also equally suggests that there is little sense in looking at literature more than 10 or 15 years old on fusion takedowns as the two conditions are likely completely different. Most patients do not like a hip fusion. There are long-term problems with low back pain, ipsilateral global instability and contralateral patellofemoral osteoarthritis. A stiff hip produces a poor quality of life, especially in a tall person. The main problem in doing a hip fusion takedown is the condition of the abductors muscles. If fused before growth was complete, there may be pelvic hypoplasia. If the pelvis is small, the glutei will also be small. Sometimes, the glutei may have undergone fatty degeneration. This can be assessed by means of an MRI. If the abductors were damaged during fusion, a limp may persist. Other problems are that leg lengthening is difficult to achieve any longstanding hip fusion. Lengthening of 1–2 cm is usually about all that can safely be achieved. If the hip was fused in childhood, there is likely to be femoral hypoplasia. There is also likely absence of proximal cancellous bone and the proximal femur is a thin brittle cortical tube. The greater trochanter should not be detached as it is difficult to obtain union under such circumstances. The approach, which I prefer for a fusion takedown is an anterior Smith Peterson. The glutei are slid off the pelvis sidewall and then the upper part of the fusion can be exposed, blunt Hohmans can then be passed around the femoral neck prior to transection. Obviously, if any AO cobra plate has been used for a fusion, a trochanteric osteotomy may be required to preserve any glutei left. Old hardware can be removed either concurrently or as an interval procedure. In 1986, I published the results of 20 cases with a five to 40-year fusion time (mean 19). I used a variety of implants. Flexion was achieved to 90 degrees at 12 months in about 88% of people. Seventy-five percent ceased to limp by year one, although the elderly limp when tired. One patient was dissatisfied with the procedure. One was revised for pain. I have reviewed the cases done in the last 20 years. These were 28 cases, two bilateral. Seven were spontaneous fusions. Twenty-one were formal hip fusions. One was an AO fusion with a cobra plate. There were various intra-operative complications including two calcar cracks, which were wired, three femoral shaft fractures, which necessitated the use of long stems. There was one drop foot, which recovered. At review, a limp was absent in 20%, mild in 12% and severe, i.e. Trendelenburg positive in 68%. Harris hip scores were excellent in 28%, good in 32%, fair in 16% and poor in 24%. Four patients only, however, continued to use canes. The eventual range of movement was good. In 80%, more than 90 degrees of flexion was obtained, but it took up to two years to obtain maximum flexion. In 12%, the range of motion was poor at being 50 degrees to 85 degrees. The range of motion was poor, i.e. less than 45 degrees in one bilateral case of athrogryposis. This was a stiff arthrogrypotic. Further surgery is required in several cases. An ipsilateral total knee replacement and one a supracondylar femoral osteotomy. One cup loosened and was revised at seven years and one liner was exchanged at ten years

Background. Tapered cementless femoral components have been used in total hip arthroplasty (THA) constructs for more than 20 years. The Synergy femoral component was introduced in 1996 as a second generation titanium proximally porous-coated tapered stem with dual offsets to better restore femoral offset at THA (Figure 1). The purpose of this study was to evaluate the outcome of the authors' experience using the Synergy stem at minimum 15 years of follow-up. Material and methods. We retrospectively reviewed a consecutive series of 102 patients (112 hips) who underwent surgery between November 1996 and October 1998 for primary THA using cementless Synergy stem with a minimum 15-years follow-up. The mean age at the time of surgery was 61 years, and the mean duration of follow-up was 16.3 years. Seventeen patients were lost at FU (8 died before the 15 years mark, 8 changed residency, 1 not willing to be seen) with no problems related to the replaced hip. Ninety-four hips in 85 patients were available for clinical and radiologic analysis. Clinical results of the 94 THAs with more than 15 years of follow-up were assessed preoperatively and postoperatively at 5, 10 and 15 years by means of standard evaluation tools: SF12, WOMAC and Harris Hip Score. Thigh pain frequency and intensity were also recorded. Radiographic analysis (Figure 2) was focused on stem alignment, bone ingrowth, radiolucent lines presence, width and progression, stress-shielding and heterotopic ossification (HTO). Student paired test and Kaplan-Meier survival analysis were used for statistical analysis. Results. All clinical evaluation tools showed at 5-year FU, 10-year FU and at latest FU (15–17 years) a statistically significant improvement compared to the preoperative scores. We observed a not constant thigh pain in 5 hips (4.75%). Nine stems were revised due to polyethylene wear (3 cases), late periprosthetic fracture (2 cases), infection (2 cases), subsidence (1 case) and instability (1 case). Stem related revision was a case of subsidence, related to occult intraoperative calcar crack and early revised (within 1 year); cumulative stem-related survival rate at 15 years was 99%. Alignment was varus in 5 cases and valgus in 1. Bone in-growth was observed in 93 hips (98%). Radiolucent lines were uncommon, non progressive, less than 2 mm, in Gruen zones 2 and 6. Stress-shielding was present as cortical reaction in 5 femurs in Gruen zones 3 and 5. Fifteen cases of HTO (grade I and II in 12 case and grade III in 3 cases) were observed. Conclusions. The Synergy stem demonstrated excellent clinical and radiographic results at 15–17 years FU in 85 patients. Survivorship (with stem revision as end point) was 99% at 15 years. Thigh pain was uncommon and the level of activity and autonomy is excellent. Radiographically bone ingrowth is evident in all stems and radiolucent lines are “benign” with no aseptic loosening

A prospective study of displaced femoral neck fractures was conducted, using the Corail® stem, a non cemented HA-coated device, provided with a bipolar head. 293 consecutive patients were included. Our reasons to shift to an uncemented implant were:. the existence of intraoperative deaths during cementation;. Cardiac failures consecutive to overhydration during cementation (to prevent drop of blood pressure);. As life expectancy increases, concerns about skeletal fixation of cemented devices in osteoporotic patients, when the cortico-medullary index decreases. Follow-up was extended up to 5 years, unless the patient died before. 7 patients were lost from FU. Function was assessed every year using various clinical scores (Parker’s mobility score, Qureshi’s mental status, Jensen’s autonomy index,). An X-Ray was obtained at each visit when possible, with a special insistence at completion of the follow up (136 out of the 144 still alive patients). Intraoperatively, 11 isolated calcar cracks and 1 fracture of the major trochanter were seen. In three cases, it was impossible to obtain a stable implantation. In two of these, a cemented implant was used. In the third patient, instability was not seen, leading to an 8 mm subsidence, along with thigh pain and distal hypertrophy of the femur. The 278 other patients had no intra-operative complications. Late complications were:. 1) 14 patients had a secondary subsidence of their device (1–4 mm), with a subsequent good stability and unaltered fixation to the skeletal tissue;. 2) No loosening;. 3) One femoral fracture, due to a second fall (at M4) requiring ORIF;. 4) 14 small radiolucent line of less than 1 cm in the major trochanter area, whose the meaning remains obscure, as no adverse reactions are seen thereafter;. 4) no stress shielding, despite a full coating of HA

Total hip arthroplasty (THA) in patients with developmental dysplasia of the hip (DDH) has been associated with increased rates of complications and revision. Hip instability and wear-induced osteolysis are among the more common and serious of these problems. The current investigation prospectively assessed the survivorship and clinical results of patients with DDH treated by alumina ceramic-ceramic THA. We investigated 161 consecutive hips in 145 patients with DDH classified as Crowe type I (131 hips, 81%), II (26 hips, 16%), III (2 hips, 1%), and IV (2 hips, 1%). All patients had an uncemented titanium acetabular component with a flush mounted alumina ceramic-ceramic bearing. The mean age at operation was 48.0 ± 12.2 years (range, 18 – 79 years). The preoperative Merle d'Aubigné score was 11.4 ± 1.7 (6 – 15). 27 hips (17%) had at least one previous surgical procedure. 92 hips (57%) were replaced with the use of surgical navigation for acetabular component positioning. The mean cup diameter was 49.9 ± 3.4 mm (46 – 60 mm). 88 (55%) bearings were 28mm and 73 (45%) bearings were 32mm. At a mean follow-up of 6.1 ± 2.5 years (2 – 11.3 years), the mean Merle d'Aubigné score was 17.4 ± 0.9 (14 – 18). There were no cases of osteolysis or dislocation. There was one reoperation of an early displaced cup. In addition, there was one calcar crack that was cerclaged, one intraoperative trochanteric fracture also repaired at surgery. No patient complained of squeaking. 94 patients with 100 hips (61%) completed a questionnaire specifically asking for squeaking. None of these patients reported squeaking. The 10-year Kaplan Meier survivorship of the implants (revision of any component for any reason) was 99.4% (95% confidence interval 98.2-100%). Results of ceramic-ceramic THA in young patients with low to middle graded DDH after two to eleven years follow-up are promising with no radiographic signs of osteolysis or dislocation

Anterior supine intermuscular total hip arthroplasty (ASI-THA) has emerged as a muscle sparing, less-invasive procedure. The anterior interval is both intermuscular and internervous, providing the advantages of little or no muscle dissection, and a true minimally invasive alternative. It is versatile, with reported use expanding beyond the primary realm to revision and resurfacing THA as well as treatment of acute fracture in elderly patients, who due to their diminished regenerative capacity may benefit more from the muscle-sparing nature of the anterior approach. The ASI approach involves the use of a standard radiolucent operative table with the table extender at the foot of the bed and the patient supine. Fluoroscopy is used in every case. A table-mounted femur elevator is utilised to facilitate femoral preparation. A retrospective review identified 824 patients undergoing 934 consecutive primary ASI-THA performed between January 2007 and December 2010. Age averaged 63.2 years (27‐92), BMI averaged 29.9 kg/m2 (16.9–59.2). Gender was 49% males and 51% females. Stem types were short in 82% and standard length in 18%. Follow-up averaged 23.1 months (1‐73). Operative time averaged 63.1 minutes (29‐143). Blood loss averaged 145.3 mL (25‐1000). Transfusion rate was 3.3% (30 of 914) in single procedures and 80% (8 of 10) in simultaneous bilateral procedures. Length of stay averaged 1.7 days (1‐12). Intraoperatively there were 3 calcar cracks and 1 canal perforation treated with cerclage cables. There were 6 wound complications requiring debridement. Four hips had significant lateral femoral cutaneous nerve parathesias not resolved at 12 months. One femoral nerve palsy occurred. At up to 73 months follow-up there have been 21 revisions (2.2%): 2 infection, 1 malpositioned cup corrected same day, 5 metal complications, 2 dislocations, 2 loose cups with one requiring concomitant stem revision secondary to inability to disarticulate trunnion, 1 femoral subsidence and 8 periprosthetic femoral fractures. Primary THA can be safely performed utilising this muscle-sparing approach. We did not see an alarmingly high rate of complications. Instead, rapid recovery and quick return to function were observed. ASI-THA appears to be safe. The recovery advantage utilising this surgical approach is irrefutable. There are complications, most notably periprosthetic femur fracture. The rate, however, appears to be low and decreases with increased experience. There is no need for a special operative or fracture table to perform the procedure. Whether the complication rate is higher with the use of these expensive devices is unknown, but our results demonstrate a 2.2% reoperation rate with the use of the ASI approach performed on a standard OR table. Continued refinement of the technical aspects of ASI-THA may lessen the complication rate

Total hip arthroplasty (THA) in patients with developmental dysplasia of the hip (DDH) has been associated with increased rates of complications and revision. Hip instability and wear-induced osteolysis are among the more common and serious of these problems. The current investigation prospectively assessed the clinical results and the survivorship of patients with DDH treated by alumina ceramic-ceramic THA. We investigated 164 consecutive hips in 147 patients with DDH. Twenty-five hips (15%) had prior surgery to improve acetabular coverage, 108 hips (66%) were classified as Crowe type I, 21 (13%) as type II, and 10 (6%) as type III. All patients had an uncemented titanium acetabular component with a flush mounted alumina ceramic-ceramic bearing and were treated between 1997 and 2006. The mean age at operation was 48.5 ± 12.2 years (range, 18–75 years). The preoperative Merle d’Aubigné score was 11.3 ± 1.6 (6–15). Ninety-four hips (57%) were replaced with the use of surgical navigation for acetabular component positioning. The mean cup diameter was 51.2 ± 3.9 mm (46–60 mm). Seventy-seven (47%) bearings were 28mm and 87 (53%) bearings were 32mm. At a mean follow-up of 4.5 ± 2.3 years (2–10 years), the mean Merle d’Aubigné score was 17.5 ± 1.2 (14–18). There were no cases of osteolysis or dislocation. There was one reoperation of an early displaced cup. In addition, there was one calcar crack that was cerclaged, one intraoperative trochanteric fracture also repaired at surgery. No patient complained of squeaking. Ninety-four patients with 100 hips (61%) completed a questionnaire specifically concerning squeaking. None of these patients reported on squeaking either. The 10-year Kaplan Meier survivorship of the implants (revision of any component for any reason) was 99.1% (95% confidence interval 98.0–100%). Results of ceramic-ceramic THA in young patients with low to middle graded DDH after two to ten year follow-up are promising with no radiographic signs of osteolysis or dislocation

Anterior supine intermuscular total hip arthroplasty (ASI-THA) has emerged as a muscle sparing, less-invasive procedure. The anterior interval is both intermuscular and internervous, providing the advantages of little or no muscle dissection, and a true minimally invasive alternative. It is versatile, with reported use expanding beyond the primary realm to revision and resurfacing THA as well as treatment of acute fracture in elderly patients, who due to their diminished regenerative capacity may benefit more from the muscle-sparing nature of the anterior approach. The ASI approach involves the use of a standard radiolucent operative table with the table extender at the foot of the bed and the patient supine. Fluoroscopy is used in every case. A table-mounted femur elevator is utilised to facilitate femoral preparation. A retrospective review identified 824 patients undergoing 934 consecutive primary ASI-THA performed between January 2007 and December 2010. Age averaged 63.2 years (27–92), BMI averaged 29.9 kg/m2 (16.9–59.2). Gender was 49% males and 51% females. Stem types were short in 82% and standard length in 18%. Follow-up averaged 23.1 months (1–73). Operative time averaged 63.1 minutes (29–143). Blood loss averaged 145.3 minutes (25–1000). Transfusion rate was 3.3% (30 of 914) in single procedures and 80% (8 of 10) in simultaneous bilateral procedures. Length of stay averaged 1.7 days (1–12). Intraoperatively there were 3 calcar cracks and 1 canal perforation treated with cerclage cables. There were 6 wound complications requiring debridement. Four hips had significant lateral femoral cutaneous nerve parathesias not resolved at 12 months. One femoral nerve palsy occurred. At up to 73 months follow-up there have been 21 revisions (2.2%): 2 infection, 1 malpositioned cup corrected same day, 5 metal complications, 2 dislocations, 2 loose cups with one requiring concomitant stem revision secondary to inability to disarticulate trunnion, 1 femoral subsidence and 8 periprosthetic femoral fractures. Primary THA can be safely performed utilising this muscle-sparing approach. We did not see an alarmingly high rate of complications. Instead, rapid recovery and quick return to function were observed. ASI-THA appears to be safe. The recovery advantage utilising this surgical approach is irrefutable. There are complications, most notably periprosthetic femur fracture. The rate, however, appears to be low and decreases with increased experience. There is no need for a special operative or fracture table to perform the procedure. Whether the complication rate is higher with the use of these expensive devices is unknown, but our results demonstrate a 2.2% reoperation rate with the use of the ASI approach performed on a standard OR table. Continued refinement of the technical aspects of ASI-THA may lessen the complication rate

Aims

Instability is a common cause of failure after total hip arthroplasty. A novel reverse total hip has been developed, with a femoral cup and acetabular ball, creating enhanced mechanical stability. The purpose of this study was to assess the implant fixation using radiostereometric analysis (RSA), and the clinical safety and efficacy of this novel design.

Background: Poor results were observed at medium term follow-up (FU) after first and second generation cementless stems implantation in total hip arthroplasty (THA). Revision rate up to 24% is reported with anatomic stems; stress-shielding rate up to 50%, thigh pain rate up to 21%, loosening rate up to 20% and osteolysis rate up to 29% were reported with cylindrical stems. A third generation tapered stem, the Synergy stem, was introduced in 1996 to rise such weakness points. Material and methods: A retrospective, cohort study was carried out in two academic centers (London, Toronto, Canada & Rome, Italy) on 232 primary THA in 215 patients with a 10 to 12 yrs FU. Mean age at surgery was 60 yrs (18–82), 95 patients were males and 120 females. Thirty-six patients were lost at FU (13 died before the 10 yrs mark, 22 changed residency, 1 not willing to be seen) with no problems related to the replaced hip. Remained at FU 196 THA. Patients selection: Dorr type A and B femurs suitable for receive a Synergy stem. Its characteristics are the following: Ti-6Al-4V, straight, tapered, 3D wedge cross-section, proximal antirotational fins, low-profile neck, neck angle 131°, metaphyseal part porous or HA coated, diaphyseal part grit blasted, polished tip, surgeon-friendly ancillary instruments. Clinical results of the 196 THA with more than 10 yrs of FU were assessed preoperatively and postoperatively at 5 and 10 or 11 or 12 yrs by means of standard evaluation tools: SF12, WOMAC and Harris Hip Score. Thigh pain frequency and intensity were also scored. Radiographic analysis was focused on stem alignment, bone ingrowth, radiolucent lines presence, width and progression, stress-shielding, heterotophic ossification (HTO). Student paired test and Kaplan-Meier survival analysis were used for statistical analysis. Results: All clinical evaluation tools showed both at 5 years FU and at latest FU (10–12 years) a statistically significant (p=0,001) improvement compared to the preoperative scores. We observed a not constant thigh pain in 7 patients (5,5%). Nineteen patients (10%) underwent evision due to polyethylene wear (6 cases), late periprosthetic fracture (5 cases), subsidence (2 cases), instability (3 cases), infection (3 cases). Cumulative survival rate was 97% at 2 and 5 years, 90% at 10 years. Stem related revisions were the 2 cases of subsidence, both related to occult intraoperative calcar crack and early revised (within 1 year); cumulative stem-related survival rate at 10 years was 99%. Alignment was varus in 9 cases and valgus in 3. Bone in-growth was observed in 194 patients (98%). Radiolucent lines were uncommon, non progressive, less than 2 mm, in Gruen zones 2 and 6. Stress-shielding was present as cortical reaction in 5 femurs in Gruen zones 3 and 5. Thirty-four cases of HTO (grade I and II in 27 case and grade III in 7 cases) were observed. Conclusions: The Synergy stem demonstrates excellent clinical and radiographic results at 10–12 yerars FU in 196 patients. Survivorship (with stem revision as end point) is 99% at 10 years. Thigh pain is uncommon and the level of activity and autonomy is excellent. Radiographically bone ingrowth is evident in all stems and radiolucent lines are “benign” with no aseptic loosening. Attention must be paid at the moment of stem press fit insertion to avoid occult proximal femoral fractures that may require revision surgery

Aims

“Get It Right First Time” (GIRFT) and NHS England’s Best Practice Tariff (BPT) have published directives advising that patients over the ages of 65 (GIRFT) and 69 years (BPT) receiving total hip arthroplasty (THA) should receive cemented implants and have brought in financial penalties if this policy is not observed. Despite this, worldwide, uncemented component use has increased, a situation described as a ‘paradox’. GIRFT and BPT do, however, acknowledge more data are required to support this edict with current policies based on the National Joint Registry survivorship and implant costs.

Objectives

Few studies have assessed outcomes following non-metal-on-metal hip arthroplasty (non-MoMHA) revision surgery performed for adverse reactions to metal debris (ARMD). We assessed outcomes following non-MoMHA revision surgery performed for ARMD, and identified predictors of re-revision.